A Study of AL102 in Patients With Progressing Desmoid Tumors
Clinical trial NCT04871282 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04871282
- Sponsor
- Immunome, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2025-12-03
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.